SOAT1 and COVID-19: This shows that inhibiting the cytokine storm via the JAK-STAT signaling pathway could be a promising way to improve current COVID-19 clinical management strategies (Convertino et al., 2020; Ingraham et al., 2020; Luo et al., 2020; Seif et al., 2020).